Page 4 - Hibitane Practice and Information Guide V7
P. 4

Our Survey                     Using Hibitane
                                                                     TM
                       Said                      Obstetric Cream

           Derma UK conducted a survey of 141   Hibitane  Obstetric Cream is widely used
                                                    TM
           Healthcare Professionals and found the   by Healthcare Professionals
           following :                       during physical internal examinations, and
                 10
           •   75% of those questioned in Maternity and   during labour and delivery in Obstetric and
             Delivery use Hibitane  Obstetric Cream
                           TM
           •   93% who use Hibitane  Obstetric Cream    Gynaecological practice.
                            TM
             use it at least weekly          Hibitane  Obstetric Cream is licensed
                                                    TM
           •   64% of those questioned who work in   for use in a variety of Gynaecological
             Obstetrics and Gynaecology stated that, in   and Obstetric procedures. Common
             their opinion using a lubricant that contains
             Chlorhexidine would help to     uses include Spontaneous Vaginal
             reduce infections within their department.  Deliveries, Assisted Deliveries and PV
           Of those questioned who stated they use   Examinations.
           Hibitane  Obstetric Cream as a lubricant in   Hibitane  Obstetric Cream may
                 TM
                                                    TM
           Obstetric and Gynaecological practice:
             •   68% use Hibitane  Obstetric Cream    be spread onto the gloved hand of the
                           TM
               for vaginal examinations      examiner and applied liberally to the skin
             •   41% use Hibitane  Obstetric Cream   around the vulva and perineum of the
                          TM
               during delivery               patient.
             •   30% use Hibitane  Obstetric Cream
                           TM
               for other actions,
               including instrument lubrication and
               cleaning the skin
                                    For more details contact us:
                                    E:  info@dermauk.co.uk
                                    W:   dermauk.co.uk
                                    T:   0191 375 9020
                                    Derma UK Ltd, Toffee Factory, Ouseburn,
                                    Newcastle upon Tyne NE1 2DF.
      Hibitane TM   Obstetric Cream - Abbreviated Prescribing Information  References:
      Presentation: Hibitane TM  Obstetric Cream is a cream containing Chlorhexidine Gluconate   1. Derma UK Ltd., ‘Summary of Hibitane TM  Obstetric Cream Product Characteristics
      1% w/w. Indication: An antimicrobial preparation for use as an antiseptic and lubricant in   (SmPC).’ 2021 2. A, Fayez Bakr et al, Effect of Cleansing the Birth Canal with Antiseptic
      obstetric and gynaecological practice. Dosage and Administration: Apply liberally to the   Solution on Maternal and Neonatal Mortality in Alexandria, American Journal of
      skin around the vulva and perineum of the patient, and to the gloved hands of the midwife   Paediatrics. July 2002, p. 379-383 3. Stray-Pedersen B et al, Vaginal disinfection with
      or doctor. Contraindications: Contraindicated for patients who have previously shown a   chlorhexidine during childbirth, Int J Antimicrob Agents. 1999 Aug;12(3):245-251. 4. E
      hypersensitivity reaction to chlorhexidine. However, such reactions are extremely rare. Warnings   Taha T et al, Effect of cleansing the birth canal with antiseptic solution on maternal and
      and Precautions: For topical application only. Keep out of the eyes and ears and avoid contact   newborn morbidity and mortality in malawi: clinical trial, BMJ 1997; 315 doi. 1997 July
      with the brain and meninges. Local stinging and/or chemical burns have been reported following   26. 5. M McClure E et al, The use of chlorhexidine to reduce maternal and neonatal
      off-label use of gauze packs soaked in Hibitane TM  Obstetric Cream and left intra-vaginally for   mortality and morbidity in low-resources settings, Int J Gynaecol Obstet. 2007 May, p.
      prolonged periods. Undesirable Effects: Irritative skin reactions can occasionally occur. Generalised   89-94. 6. Adriaanse AH et al, Randomized study of vaginal chlorhexidine disinfection
      allergic reactions to chlorhexidine including anaphylaxis have been reported but are extremely   during labor to prevent vertical transmission of group B streptococci. 1995 Aug, p. 135-141.
      rare. Package Quantities: 10 x 50ml and 250ml bottle. Pharmaceutical Precautions: Store below   7. Thomas-D et al, Activity of different antiseptics on Chlamydia trachomatis, Pathol-Biol,
      30°C. Basic NHS Price: £49.00 (10 x 50ml) and £22.00 (1 x 250ml). Legal Category: GSL. Marketing   1984, 32/5 Bis, p. 544-546. 8. Osborn-M-F et al, Effect of various analgesics and lubricants
      Authorisation Number: PL 19876/0009. Marketing Authorisation Holder: Derma UK Ltd, Toffee   on isolation of Chlamydia trachomatis and Neisseria gonorrhoeae. J-Clin Microbial,
      Factory, Ouseburn, Newcastle upon Tyne, NE1 2DF, UK. “Hibitane” and “Derma UK” are registered Trade   1982, 15/3, p. 522-524. 9. Modak S et al, Rapid inactivation of infectious pathogens by
      Marks. Date of Revision of Text: January 2024.  chlorhexidine-coated gloves, Dept of Surgery, Columbia University, NY, NY, Infect Control
       Please refer to the full SmPC before prescribing this product. Adverse events should be reported.    Hosp Epidemiol 1992 Aug, 13 (8) p. 463- 471. 10. Derma UK LTD, Hibitane TM  Obstetric Cream
        Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for    Research, 2018 March. Data on file.
       MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported
                 to Derma UK on +44 (0) 191 375 9020.  HIB/109/0124                                                          Date of Preparation: January 2024
   1   2   3   4